Baillie Gifford - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$14,172
+2.7%
3150.0%0.00%
Q4 2022$13,800
-34.3%
3150.0%0.00%
Q3 2022$21,000
+31.2%
3150.0%0.00%
Q2 2022$16,000
-20.0%
3150.0%0.00%
Q1 2022$20,000
-41.2%
3150.0%0.00%
Q4 2021$34,000
-2.9%
315
-8.2%
0.00%
Q3 2021$35,000
-2.8%
343
-15.1%
0.00%
Q2 2021$36,000
-12.2%
404
-5.2%
0.00%
Q1 2021$41,0004260.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders